Understanding Peptide Purity

In peptide analysis, purity is almost always reported as HPLC area-percent: the sample is separated by high-performance liquid chromatography, a UV detector records every component that elutes from the column, and the area under the main peak is expressed as a percentage of the total area of all peaks. A result of 99.2% means that, of everything the detector saw, 99.2% was the main component.

That definition carries three important caveats. First, it is relative, not absolute: it tells you the proportion of UV-absorbing material that is the target peptide, not the mass of peptide in the vial. Second, it only counts what the detector can see at the chosen wavelength, typically 214 or 220 nm where the peptide bond absorbs. Third, it says nothing about non-peptide content such as residual water, counter-ions or salts, which is why a 99% pure peptide can still have a peptide content by weight of 80–90%.

Two laboratories can report different purity figures for the same vial if they use different gradients, columns, wavelengths or integration settings. A shallow gradient resolves closely related impurities (deletion sequences, oxidised variants) that a fast gradient merges into the main peak, so a faster method tends to flatter the result. Detection at 280 nm sees only aromatic residues and will miss impurities that lack them.

For this reason a credible certificate states the method: column type, mobile phases, gradient, flow rate, detection wavelength and injection volume. A purity figure with no method behind it cannot be compared with anything and should be treated as a claim rather than a measurement.

A single sharp peak at 99% proves that the sample is homogeneous. It does not prove that the homogeneous material is the compound on the label. A pure sample of the wrong peptide, or a sequence with one residue substituted, can look identical by HPLC. Identity is confirmed separately by mass spectrometry, which measures molecular weight and, in tandem mode, can sequence the peptide. A complete batch record therefore shows both an HPLC purity result and a mass-spectrometry identity result, and the two are read together.

Solid-phase synthesis introduces a predictable family of impurities. Deletion sequences arise when a coupling step fails and a residue is skipped. Truncated sequences are chains that stopped growing. Incompletely deprotected peptides retain a side-chain protecting group. Oxidation affects methionine, cysteine and tryptophan. Racemisation can occur at histidine and cysteine during coupling. Most are removed by preparative HPLC after synthesis, but traces remain and appear as small peaks near the main peak on the analytical chromatogram.

Purity above 98% is standard for well-made research peptides. The difference between 98% and 99.5% is rarely meaningful for most laboratory applications; what matters far more is that the result was produced by a documented, independent method and that identity was confirmed alongside it.

Every batch we release is analysed by an independent laboratory, Janoshik Analytical, using HPLC for purity and mass spectrometry for identity. The batch reference on your vial links to the certificate, which can be viewed on the laboratory's own verification site rather than only on ours. You can search current records on our lab reports page.